Brian Gorman
Consejero General en CALLIDITAS THERAPEUTICS AB .
Perfil
Brian Gorman is currently the Group General Counsel at Calliditas Therapeutics AB since 2024.
Prior to this, he worked as the EVP-Corporate Development & General Counsel at Opiant Pharmaceuticals, Inc. and as the Vice President & Assistant General Counsel at Endo Pharmaceuticals, Inc. He completed his undergraduate degree at Gettysburg College and his graduate degree at Villanova University School of Law.
Cargos activos de Brian Gorman
| Empresas | Cargo | Inicio |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Consejero General | 01/01/2024 |
Antiguos cargos conocidos de Brian Gorman.
| Empresas | Cargo | Fin |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Consejero General | 02/03/2023 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Consejero General | - |
Formación de Brian Gorman.
| Villanova University School of Law | Graduate Degree |
| Gettysburg College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Brian Gorman
